PEB - Pacific Edge Ltd

[Schrodinger]

Today I noticed a couple of posts regarding expectations which I just found a bit peculiar, well, in addition to simply being just totally incorrect.

For those interested in reading the 2011 prospectus and the 2013 US commercialisation pathway presentations, you will find that PEB are exactly on track in terms of both schedule and sales. All due largely to committed and focused management I believe.

If you wish to DYOR you can find these documents on the PEB website along with others.

Sure and steady progress, and it's all up from here.

What are the financial numbers? Not interested in test results and other fluff, more interested to see what they are selling from their current product range.

[Schrodinger]

I agree the AGM presentation available online was a bit poor and confusing in layout.

But there is plenty more evidence out there about the execution for commercialisation of CxBladder by Darling and his US counterpart. You do a disservice to yourself as an investor to describe their lab as a "Soviet style building". Apparently it is nothing short of state of the art.

If you read over the presentation again, you will see their sales map, plus also their first three hires (sales executives). This is a pretty good clue as to their methodology for approaching the USA.

That maybe true Sparky, but posting a picture of a large building tells me nothing as an investor. Do they own the building and was it prudent to spend money on this over their obvoius need for sales and marketing attention... or are they refitting 2 rooms/floors etc? What was the capital outlay and ROI?

Since there are three of them and are obvious superstars, it interests me why they chose PEB over other obvious companies that would love to have them due to their impressive achievements.

I see alot of companies fail in the USA and this is because they cant sell. I hope they are an exception.

[MAC]

A little patience will be rewarded Schrodinger.

We are all genuinely interested in seeing PEB prosper, and it should be an interesting watch over the next three months leading up to PEB's first half year report on US sales.

The share market leads sales performance and reacts if that performance does not unfold. We should start to see the market beginning to back the company now and build in some anticipation of an adequate HY14 sales report.

With five years of growth ahead, it's all up from here.

[Schrodinger]

A little patience will be rewarded Schrodinger.

We are all genuinely interested in seeing PEB prosper, and it should be an interesting watch over the next three months leading up to PEB's first half year report on US sales.

The share market leads sales performance and reacts if that performance does not unfold. We should start to see the market beginning to back the company now and build in some anticipation of an adequate HY14 sales report.

With five years of growth ahead, it's all up from here.

O
k, the next information release will be interesting.

[Twinklefingers]

That maybe true Sparky, but posting a picture of a large building tells me nothing as an investor. Do they own the building and was it prudent to spend money on this over their obvoius need for sales and marketing attention... or are they refitting 2 rooms/floors etc? What was the capital outlay and ROI?

Since there are three of them and are obvious superstars, it interests me why they chose PEB over other obvious companies that would love to have them due to their impressive achievements.

I see alot of companies fail in the USA and this is because they cant sell. I hope they are an exception.

I'm pretty sure it's been mentioned in one of their previous reports that they are one of the people leasing space in that building.

Also it's at the Hershey Research Center amongst numerous other medical companies. Interestingly (to me at least) Jack Atchason who is listed as Director of Strategic Accounts for PEDUSA is actually Executive Director at the Hershey Research Center so while working at PEDUSA isn't his only job he's going to have some pretty solid contacts in the industry and hopefully experience with other companies in PEDUSAs situation. I'd say the fact he chose PEB over "other obvious companies" shows he thinks they have a good shot at success.

[barney]

The presentation that was given at the agm was perfectly adequate to me. Sure it was'nt some slick glossy piece of spin put out by a comminications division or PR firm, but I've seen plenty of those over the years and I know which I would rather have.

The amount of floor space leased in the Hershey building, the cost of the fitout, potential additional space has all been previously disclosed by Pacific Edge.

[benjitara]

I find it heartening reading through the history of the ASX listed Prana Bio (pbt) and seeing the positive differences and same strengths as that of PEB. While the products that companies provide are totally different I do get the feeling that PEB have truly cracked the large hurdles of commercialisation and positive clinical trials. To me this provides the company with a tangible way forward which we are about to start seeing.PEB certainly have kept their cards close to their chest which for me is only strengthening my support.

[barney]

Todays NBR has an article on Pacific Edge in their Margin Call column written by David Williams.

It does'nt appear to be available online but its hardcopy edition is probably worth a read, although there is nothing particularly new being revealed.

It mentions the recently completed DHB user programmes, Canterbury and Waitemata, and that David Darling has met with Tony Ryall this week for the second time. Also mentions a customer in the US who is about to embark on the user programme and whose size is roughly three times the size of all the NZ health boards combined.

[MAC]

Fantastic news thanks Barney, I'm off to buy a copy.

Hopefully a market announcement will soon follow, they would seem to be market appropriate announcements given PEB's stage in business.

[CJ]

It does'nt appear to be available online but its hardcopy edition is probably worth a read,

The one think holding me back from getting a subscription. Some fo their stuff is free but then they have two different premium products (online and print).

Also mentions a customer in the US who is about to embark on the user programme and whose size is roughly three times the size of all the NZ health boards combined.

BOOM

Lets hope they pull it off.